Reset filter
Nyckelord
GIPERTENZIIA ×
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
    1. 1.1. Inkluderande/exkluderande
    1. 1.2. Anamnes
    1. 1.3. Kroppsundersökning
    1. 1.4. Poäng
    1. 1.5. Apparativ diagnostik
    1. 1.6. Laboratorium
    1. 1.7. Patologi och histologi
    1. 1.8. Upplysning/samtycke
    1. 1.9. Terapi
    1. 1.10. Operationsberättelse
    1. 1.11. Oönskad händelse
    1. 1.12. Uppföljning
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

414 Sökresultat.
Relevans Bedömning Nya först Gamla först

Eligibility Hypertension NCT01431508

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 23 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3); ODM derived from: https://clinicaltrials.gov/show/NCT01431508

Eligibility Hypertension NCT01145391

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 12 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Trial; ODM derived from: https://clinicaltrials.gov/show/NCT01145391

Eligibility Hypertension NCT01079494

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 9 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Clinical Pharmacists Role in the Management of Hypertension in Jordan; ODM derived from: https://clinicaltrials.gov/show/NCT01079494

Eligibility Hypertension NCT01167920

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 15 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Virtual Hypertension Clinic; ODM derived from: https://clinicaltrials.gov/show/NCT01167920

Eligibility Hypertension NCT00803634

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 19 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO); ODM derived from: https://clinicaltrials.gov/show/NCT00803634

Eligibility Hypertension NCT01038895

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria; ODM derived from: https://clinicaltrials.gov/show/NCT01038895

Eligibility Hypertension NCT00549536

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00549536

Eligibility Hypertension NCT00446511

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00446511

Eligibility Hypertension NCT00435162

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00435162

Eligibility Hypertension NCT00433836

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00433836

Eligibility Hypertension NCT00853957

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00853957

Eligibility Hypertension NCT00852787

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00852787

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial